Log Out | Member Center

96°F

98°/71°

Seattle hospital testing brain trauma drug

  • The Associated Press
  • Published Wednesday, July 9, 2014, at 12:52 p.m.
  • Updated Wednesday, July 9, 2014, at 6:33 p.m.

— Patients who arrive unconscious with a head injury at Harborview Medical Center in Seattle may be given a drug being tested to prevent bleeding in the brain, even though they are unable to give their consent.

The hospital's chief trauma doctor, Dr. Eileen Bulger, says the drug known as TXA is already approved to stop internal bleeding. She's leading the study to determine if giving the drug as early as possible helps with traumatic brain injury.

The hospital is currently doing community outreach. Enrollment in the study won't begin until it gets approval from a review panel at the University of Washington.

The Seattle Times reports (http://bit.ly/VYdX4j ) that people can opt out by requesting a "NO-STUDY" bracelet (call 206-744-7724 or email pklotz@uw.edu).

The study at Harborview and nine other trauma centers will involve about 1,000 patients, and about 100 of those are at Harborview.

Information from: The Seattle Times, http://www.seattletimes.com

Subscribe to our newsletters

The Wichita Eagle welcomes your comments on news of the day. The more voices engaged in conversation, the better for us all, but do keep it civil. Please refrain from profanity, obscenity, spam, name-calling or attacking others for their views. Please see our commenting policy for more information.

Have a news tip? You can send it to wenews@wichitaeagle.com.

Search for a job

in

Top jobs